316. Carnitine cycle disorder Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 5 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 10
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Bezafibrate
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Break IN L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Break IN L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States